Viewing Study NCT00062660


Ignite Creation Date: 2025-12-25 @ 2:05 AM
Ignite Modification Date: 2026-02-21 @ 11:36 PM
Study NCT ID: NCT00062660
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2016-11-30
First Post: 2003-06-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection
Sponsor: Boehringer Ingelheim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module